市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| CAGR: | 7.4 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
患者监护设备是用于通过连续测量生命体征和反复进行医学测试来测量某些医疗参数以确保患者健康的设备。
在中国，心血管疾病等慢性病正在迅速增加。此外，中国的老年人口也在不断增长。由于这些因素，中国对患者监护设备的需求在此期间有所增加。
需求的增加也导致该领域技术进步的增加，这简化了这些设备的使用，也使它们更便携。此外，这些技术减少了不必要的去医生办公室的次数，并减少了与旅行相关的费用。因此，这些设备也被用于家庭个人使用，这也对市场增长产生了积极影响。
报告范围
根据报告的范围，患者监测设备通过使用医疗监视器并从个人收集医疗（和其他）数据，持续监测患者的重要参数，如血压和心率。
| By Type of Device | |
| Hemodynamic Monitoring Devices | |
| Neuromonitoring Devices | |
| Cardiac Monitoring Devices | |
| Respiratory Monitoring Devices | |
| Remote Monitoring Devices | |
| Other Types of Devices |
| By Application | |
| Cardiology | |
| Neurology | |
| Respiratory | |
| Fetal and Neonatal | |
| Weight Management and Fitness Monitoring | |
| Other Applications |
| By End User | |
| Home Healthcare | |
| Ambulatory Care Centers | |
| Hospitals | |
| Other End Users |
主要市场趋势
心脏病学应用有望主导市场
心脏监测是指对心脏活动进行连续或间歇性监测，并评估患者与其心律有关的状况。附加的监测组件允许根据患者诊断和治疗的需要监测和显示心血管压力和心输出量。持续的心血管和肺部监测可以迅速识别和开始治疗。
近几十年来，中国心血管疾病（CVD）的发病率呈上升趋势。根据 Liu S 等人在 JAMA Cardiology 2019 上发表的 2019 年报告，心血管疾病的患病率自 1990 年以来翻了一番，到 2016 年达到近 9400 万。从 1990 年到 2016 年，心血管疾病的年龄标准化患病率总体显着增加14.7%，缺血性心脏病 (19.1%)、缺血性中风 (36.6%)、心肌病和心肌炎 (23.1%) 和心内膜炎 (26.7%) 的发病率也是如此。因此，这增加了患病率，并有望增加用于心脏病学应用的患者监测设备。因此，这将有助于市场的整体增长。
To understand key trends, Download Sample Report
竞争格局
患者监测市场由几个主要参与者组成。中国鼓励了许多全球公司进入市场，因此，许多全球患者监测市场的参与者都在中国出现。此外，一些国内玩家也一直在中国市场展开竞争。这些因素使该地区非常具有竞争力。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rising Incidences of Chronic Diseases due to Lifestyle Changes
-
4.2.2 Growth in Geriatric Population
-
4.2.3 Growing Preference for Home and Remote Monitoring
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Technology
-
4.3.2 Stringent Regulatory Framework
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Type of Device
-
5.1.1 Hemodynamic Monitoring Devices
-
5.1.2 Neuromonitoring Devices
-
5.1.3 Cardiac Monitoring Devices
-
5.1.4 Respiratory Monitoring Devices
-
5.1.5 Remote Monitoring Devices
-
5.1.6 Other Types of Devices
-
-
5.2 By Application
-
5.2.1 Cardiology
-
5.2.2 Neurology
-
5.2.3 Respiratory
-
5.2.4 Fetal and Neonatal
-
5.2.5 Weight Management and Fitness Monitoring
-
5.2.6 Other Applications
-
-
5.3 By End User
-
5.3.1 Home Healthcare
-
5.3.2 Ambulatory Care Centers
-
5.3.3 Hospitals
-
5.3.4 Other End Users
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abbott Laboratories
-
6.1.2 Baxter International Inc
-
6.1.3 Becton, Dickinson and Company
-
6.1.4 Boston Scientific Corporation
-
6.1.5 Draegerwerk AG
-
6.1.6 GE Healthcare
-
6.1.7 Johnson & Johnson
-
6.1.8 Koninklijke Philips NV
-
6.1.9 Medtronic PLC
-
6.1.10 Siemens Healthcare GmbH
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The China Patient Monitoring Market market is studied from 2018 - 2026.
What is the growth rate of China Patient Monitoring Market?
The China Patient Monitoring Market is growing at a CAGR of 7.4% over the next 5 years.
Who are the key players in China Patient Monitoring Market?
Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company, GE Healthcare, Johnson & Johnson are the major companies operating in China Patient Monitoring Market.
